Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Hereditary Breast and Ovarian Cancer Syndrome|Osteoporosis|Ovarian Carcinoma
Interventions: OTHER: Laboratory Biomarker Analysis|DRUG: Zoledronic Acid
Sponsor: Gynecologic Oncology Group
Collaborators: National Cancer Institute (NCI)